The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Dr. Marty Makary has been outspoken about vaccine mandates and other public health measures, so how does the Food and Drug ...

The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that could affect the color of several snack foods including Skittles and Flamin ...

Used in the American food supply for decades to give treats an appealing hue, in recent years concerns have been raised over ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

Novavax said Monday that the FDA was asking the company to run a new clinical trial of its vaccine after the agency grants full approval. The company said it had responded and tha ...